Estrella ImmunopharmaESLA
13F holders, Q1 2024 (March 31)6holders
$1.22avg. 13F price*
At the end of Q1 2024, 6 institutions reported holding Estrella Immunopharma Inc. (ESLA) in their 13F filings. The largest holders were Geode Capital Management, LLC ($70K), Atw Spac Management LLC ($50K) and Hunting Hill Global Capital, LLC ($26K).
- Company
- Estrella Immunopharma Inc.
- CUSIP
- 297584104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $336 |
Ownership 6 holders
| Geode Capital Management, LLC | 0.00% | Add +3.6% | 58,214 | $70K |
| Atw Spac Management LLC | 0.06% | No change | 40,000 | $50K |
| Hunting Hill Global Capital, LLC | 0.02% | No change | 21,358 | $26K |
| MASO CAPITAL PARTNERS Ltd | 0.01% | No change | 10,000 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +781.5% | 5,571 | $7K |
| Wells Fargo & Company | 0.00% | Add +1.4% | 74 | $92 |
"% of holder's portfolio" is ESLA's weight in each manager's 13F, not the share of Estrella Immunopharma Inc. the manager owns.